跳转至内容
Merck
CN
  • The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.

The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.

Oncotarget (2017-10-06)
Erik Hilborn, Olle Stål, Andrey Alexeyenko, Agneta Jansson
摘要

To investigate the influence of estrogen, androgen, microRNAs, and genes implicated in breast cancer on the expression of HSD17B1 and HSD17B2. Breast cancer cell lines ZR-75-1, MCF7, T47D, SK-BR-3, and the immortalized epithelial cell line MCF10A were used. Cells were treated either with estradiol or dihydrotestosterone for 6, 24, 48 hours, or 7 days or treated with miRNAs or siRNAs predicted to influence HSD17B expression Results and discussion. Estradiol treatment decreased We show that

材料
产品编号
品牌
产品描述

Sigma-Aldrich
羟基氟他胺, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human ESR1